Myeloma

Top Story

City of Hope names director of pharmaceutical initiatives

October 21, 2017

George Somlo, M D, has been appointed director of pharmaceutical initiatives at City of Hope.

Somlo, recognized for his research related to breast cancer and hematology, serves as professor with joint appointments in the departments of medical oncology/therapeutics research and hematology/hematopoietic cell transplantation. He also serves as president of City of Hope’s medical staff and a member of its board of directors.

AACR: Advances in cancer research, medical funding allow for ‘phenomenal’ progress

October 17, 2017
Oncology leaders who participated in an American Association for Cancer Research webinar this afternoon highlighted several advances in cancer research and emphasized…

NIH collaboration aims to identify, validate immunotherapy biomarkers

October 13, 2017
NIH launched the Partnership for Accelerating Cancer Therapies, a 5-year public-private research collaboration. The $215 million effort is part of the national cancer…
In the Journals Plus

Venetoclax-based regimen may extend survival in multiple myeloma

October 11, 2017
Venetoclax with bortezomib and dexamethasone demonstrated an acceptable safety profile and promising efficacy among patients with relapsed or refractory multiple…
More Headlines »
CME

Multiple Myeloma Patient Management: Embracing New Advancements, Overcoming New Challenges

Support for this activity has been provided through educational grants from Amgen; Celgene Corporation; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Takeda Oncology.

The multiple myeloma clinical landscape has evolved significantly, with not only 10 new drugs but also new staging…
More »
Video

Baseball star who survived melanoma ‘suffering’ from lack of sunscreen use

September 22, 2017
More »
Resource Centers
European Society for Medical Oncology Congress

European Society for Medical Oncology Congress

Advertisement
Advertisement